Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Cantor Fitzgerald Analyst
Timur Ivannikov is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/27/2025 | PRQR | Buy Now | ProQR Therapeutics | $2.40 | 233.33% | $8 → $8 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/14/2025 | PHVS | Buy Now | Pharvaris | $24.37 | 2.59% | $28 → $25 | Maintains | Overweight | Get Alert | |
| 05/14/2025 | ATXS | Buy Now | Astria Therapeutics | $12.92 | 263.78% | $47 → $47 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/07/2023 | GOSS | Buy Now | Gossamer Bio | $3.88 | 28.87% | → $5 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/06/2023 | ANAB | Buy Now | AnaptysBio | $47.63 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 07/08/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 543.27% | → $22 | Initiates | → Outperform | Get Alert | |
| 04/18/2022 | GOSS | Buy Now | Gossamer Bio | $3.88 | 389.69% | → $19 | Initiates | → Outperform | Get Alert | |
| 03/01/2022 | APLS | Buy Now | Apellis Pharmaceuticals | $24.55 | 364.36% | $112 → $114 | Maintains | Strong Buy | Get Alert | |
| 11/15/2021 | CBIO | Buy Now | Catalyst Biosciences | $13.41 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 04/29/2021 | CBIO | Buy Now | Catalyst Biosciences | $13.41 | 41.69% | $18 → $19 | Maintains | Outperform | Get Alert | |
| 04/01/2021 | NEXI | Buy Now | NexImmune | $0.01 | 299900% | → $30 | Initiates | → Outperform | Get Alert |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.